Rights and permissions
About this article
Cite this article
Rosiglitazone: significant benefits in non-diabetic CAD. Inpharma Wkly. 1417, 19 (2003). https://doi.org/10.2165/00128413-200314170-00045
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200314170-00045